ICA1 affects APP processing through the PICK1-PKCα signaling pathway.
Liangye Ji1, ZiJun Meng1, Xiangjun Dong1
1Department of Pediatric Research Institute Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, China International Science and Technology Cooperation base of Child development and Critical Disorders, Chongqing Key Laboratory of Child Neurodevelopment and Cognitive Disorders, Children's Hospital of Chongqing Medical University, Chongqing, China.
Islet cell autoantigen 1 (ICA1) expression is reduced in Alzheimer's disease (AD). ICA1 influences amyloid precursor protein processing, suggesting it as a potential therapeutic target for AD.
Area of Science:
- Neuroscience
- Molecular Biology
- Immunology
Background:
- Islet cell autoantigen 1 (ICA1) is implicated in autoimmune disorders and may influence synaptic plasticity.
- Reduced ICA1 expression is observed in Alzheimer's disease (AD) patients, but its specific role in AD pathogenesis is not fully understood.
Purpose of the Study:
- To investigate the role of ICA1 in Alzheimer's disease (AD).
- To determine the effect of ICA1 on amyloid precursor protein (APP) processing and related signaling pathways.
Main Methods:
- Analysis of ICA1 expression in AD patient brains and an AD mouse model.
- Assessment of ICA1's impact on APP, ADAM10, and ADAM17 expression.
- Transcriptome sequencing to identify regulated pathways.
- Investigation of ICA1's effect on PKCα protein levels and phosphorylation.
Main Results:
- ICA1 expression was found to be decreased in the brains of AD patients and an AD mouse model.
- ICA1 overexpression led to increased expression of amyloid precursor protein (APP), ADAM10, and ADAM17, without altering protein half-life or mRNA levels.
- Transcriptome analysis indicated that ICA1 regulates the G protein-coupled receptor signaling pathway.
- Overexpression of ICA1 resulted in elevated PKCα protein levels and phosphorylation.
Conclusions:
- ICA1 plays a role in modulating APP processing, shifting it towards non-amyloidogenic pathways.
- Regulation of the PICK1-PKCα signaling pathway by ICA1 is a key mechanism.
- ICA1 represents a potential novel therapeutic target for Alzheimer's disease (AD).
Related Concept Videos
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
cAMP-dependent Protein Kinase Pathways
Intracellular Signaling Cascades
IP3/DAG Signaling Pathway
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Amplifying Signals via Enzymatic Cascade


